Cited by

• XTP8 Promotes Ovarian Cancer Progression by Activating AKT/AMPK/mTOR Pathway to Regulate EMT.

  Zhao R, Ning X, Lu H, Xu W, Ma J, Cheng J, Ma R. Zhao R, et al. Cell Biochem Biophys. 2024 Jun;82(2):945-957. doi: 10.1007/s12013-024-01246-4. Epub 2024 Mar 13. Cell Biochem Biophys. 2024. PMID: 38717641 Free PMC article.
• DEPDC1 and KIF4A synergistically inhibit the malignant biological behavior of osteosarcoma cells through Hippo signaling pathway.

  Yang M, Zhang H, Gao S, Huang W. Yang M, et al. J Orthop Surg Res. 2023 Feb 27;18(1):145. doi: 10.1186/s13018-023-03572-4. J Orthop Surg Res. 2023. PMID: 36849972 Free PMC article.
• ALPK2 acts as tumor promotor in development of bladder cancer through targeting DEPDC1A.

  Wang Y, Wu J, Luo W, Zhang H, Shi G, Shen Y, Zhu Y, Ma C, Dai B, Ye D, Zhu Y. Wang Y, et al. Cell Death Dis. 2021 Jul 1;12(7):661. doi: 10.1038/s41419-021-03947-7. Cell Death Dis. 2021. PMID: 34210956 Free PMC article.
• DEPTOR at the Nexus of Cancer, Metabolism, and Immunity.

  Caron A, Briscoe DM, Richard D, Laplante M. Caron A, et al. Physiol Rev. 2018 Jul 1;98(3):1765-1803. doi: 10.1152/physrev.00064.2017. Physiol Rev. 2018. PMID: 29897294 Free PMC article. Review.
• Targeted interfering DEP domain containing 1 protein induces apoptosis in A549 lung adenocarcinoma cells through the NF-κB signaling pathway.

  Wang Q, Li A, Jin J, Huang G. Wang Q, et al. Onco Targets Ther. 2017 Sep 11;10:4443-4454. doi: 10.2147/OTT.S142244. eCollection 2017. Onco Targets Ther. 2017. PMID: 28979136 Free PMC article.